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1. Background
Although somatic mutations in the Janus kinase 2 gene (JAK2) occur in many
Philadelphia-chromosome negative chronic myeloproliferative neoplasms (PN-MPNs),
disease evolution, distinct phenotypes and the continuous clinical evidence of an
increasing number of cases, with younger patients affected, have been pointing to a
growing involvement of environmental factors in the pathogenesis of these diseases.
Although this association is well established in some solid tumors, like breast and
thyroid, this aspect is now being considered for hematological malignancies.
Exposure to hazardous agents in the environment on a continual basis, can lead to
changes at the genome level, alterations in cell cycle regulation and consequently to
cancer. Several single nucleotide polymorphisms (SNPs) have been identified, that may
influence the DNA repair capacity and, in turn, confer genetic predisposition to disease
and determine therapeutic response (e.g. DNA repair, apoptosis).
On the other hand, the phenotypic pleiotropy of these disorders seems to be the result
of a combination of somatic mutation(s), inherited genetic variability, post-genetic
regulation and host modifiers (Fig. 1).
We intend to evaluate the role of base excision repair (BER) pathway SNPs in PN-MPNs
susceptibility.
2. Objectives
Our results suggest that BER polymorphisms such as rs1799782 (XRCC1-194) may
influence PN-MPNs susceptibility.
The more significant association between women can be due to the predominance of ET
cases, which has been referred in the literature as having a slight female sex
predilection. On the other hand, the lack of association in IMF cases can be due to the
small sample size.
However, larger studies are required to confirm these results and to provide conclusive
evidence of association between these and other BER variants and PN-MPNs and
therapeutic response.
5. Conclusions
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We performed a case-control study in 121 Caucasian Portuguese PN-MPNs patients (73 with Essential
thrombocythaemia (ET), 35 with Polycythaemia vera (PV) and 13 with Idiopatic Myelofibrosis (IMF)) and 280
matched controls. Most of the patients were diagnosed and are followed by some of the elements of this
working group. rs1799782 and rs25487 (XRCC1), rs1052133 (OGG1), rs1136410 (PARP1), rs13428 and
rs1050112 (PARP4), rs1130409 (APEX1) and rs3219489 (MUTYH) were genotyped using real-time PCR (RT-
PCR 7300 Applied Biosystem), through TaqMan® SNP genotyping assays (Life Technology), according to
manufacturer instructions.
Differences in genotype frequency, smoking status, age class, gender and pathology distributions between
patients and controls were evaluated using SPSS 22.0 (SPSS Inc.).
3. Methods
When considering all PN-MPNs cases, rs1799782 (XRCC1_194) was associated with
MPNs risk. A consistent increase in overall PN-MPNs risk was observed for the presence
of at least one variant allele carriers (Arg/Trp or Trp/Trp; OR=2.2, 95% CI=1.4-3.5), more
significant between women (Tables 1 and 2).
It seems that alcohol consumption also increases the risk for PN-MPNs development.
Concerning pathology stratification, IMF did not show an increased risk in association
with this polymorphism.
JAK2V617F positive cases revealed a borderline effect for the presence of at least one
variant allele carriers of XRCC1_194 (OR=1.8, 95% CI=0.98-3.4, P=0.059).
Results for PARP4_13 were not shown, since it is in linkage disequilibrium with
PARP4_01. Our data did not reveal a positive association between the other
polymorphisms individually and PN-MPNs susceptibility.
Studies related with therapeutic response are still ongoing.
4. Results
Fig. 1 – Megakaryocytes in essential thrombocythaemia, bone marrow
aspirate smear (x100). 
Characteristics Cases, n (%) Controls, n (%) P value
Gender
Male
Female
56 (29.6)
65 (30.7)
133 (70.4)
147 (69.3)
0.8
Age a, b
30-49
50-69
≥70
16 (27.1)
47 (30.5)
58 (30.9)
43 (72.9)
107 (69.5)
130 (69.1)
0.9
Smoking habits
Never
Current
93 (30.5)
28 (29.5)
212 (69.5)
67 (70.5)
0.9
Alcohol habits
Never
Social
Regular
92 (32.6)
20 (44.4)
9 (12.3)
190 (67.4)
25 (55.6)
64 (87.7)
<0.0001
MUTYH (Gln335His)
Gln/Gln
Gln/His
His/His
13 (36.1)
47 (29.6)
61 (30.2)
23 (63.9)
112 (70.4)
141 (69.8)
0.7
APEX1 (Asp148Glu)
Asp/Asp
Asp/Glu
Glu/Glu
34 (31.8)
57 (29.7)
30 (30.6)
73 (68.2)
135 (70.3)
68 (69.4)
0.9
OGG1 (Ser326Cys)
Ser/Ser
Ser/Cys
Cys/Cys
76 (29.6)
37 (30.8)
8 (40.0)
181 (70.4)
83 (69.2)
12 (60.0)
0.6
PARP1 (Val762Ala)
Val/Val
Val/Ala
Ala/Ala
96 (31.1)
25 (28.4)
0 (0.0)
213 (68.9)
63 (71.6)
1 (100.0)
0.7
PARP4_01 (Gly280Arg)
Gly/Gly
Gly/Arg
Arg/Arg
48 (31.4)
56 (28.6)
17 (35.4)
105 (68.6)
140 (71.4)
31 (64.6)
0.6
XRCC1_399 (Gln399Arg)
Gln/Gln
Gln/Arg
Arg/Arg
15 (34.1)
54 (28.7)
52 (31.5)
29 (65.9)
134 (71.3)
113 (68.5)
0.7
XRCC1_194 (Arg194Trp)
Arg/Arg
Arg/Trp
Trp/Trp
77 (26.1)
28 (33.3)
16 (94.1)
218 (73.9)
56 (66.7)
1 (5.9)
<0.0001
a Age of diagnosis for cases
b Age of control population at the time of diagnosis for the matched case
n XRCC1_194
(Arg194Trp)
OR crude
(95% CI)
OR adjusted 
(95% CI)a
All cases 121 Arg/Argb
Arg/Trp
Trp/Trp
Arg/Trp or Trp/Trp
1 (Reference)
1.4 (0.8-2.4)
45.3 (5.9-347.3)c
2.2 (1.4-3.5)*
1 (Reference)
1.5 (0.9-2.5)
40.1 (5.2-309.9)
2.3 (1.4-3.7)*
Gender
Male
Female
56
65
Arg/Argb
Arg/Trp or Trp/Trp
Arg/Argb
Arg/Trp or Trp/Trp
1 (Reference)
1.8 (0.96-3.4)
1 (Reference)
2.6 (1.4-4.5)*
1 (Reference)
2.1 (1.1-4.1)*
1 (Reference)
2.7 (1.5-4.9)*
Pathology 
stratification
ET
PV
CIM    
73
35
13
Arg/Argb
Arg/Trp or Trp/Trp
Arg/Argb
Arg/Trp or Trp/Trp
Arg/Argb
Arg/Trp or Trp/Trp
1 (Reference)
2.4 (1.4-4.1)*
1 (Reference)
2.6 (1.2-5.3)*
1 (Reference)
0.7 (0.2-3.2)
1 (Reference)
2.5 (1.4-4.4)*
1 (Reference)
2.7 (1.3-5.8)*
1 (Reference)
0.9 (0.2-4.5)
a ORs were adjusted for age (30-49, 50-69 and  ≥70), smoking status (never and current)
b The individuals with Arg/Arg genotype were considered as reference class
c Statistical error type 1 ; * P < 0.05
Table 1 – General characteristics for the PN-MPNs cases (n=121) and control 
population (n=280).
Table 2 – ORs (95% CI) for XRCC1_194 (Arg194Trp) polymorphism and PN-
MPNs association.
